Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Heaney, Liam G"'
Autor:
Menzies-Gow, Andrew, Gurnell, Mark, Heaney, Liam G, Corren, Jonathan, Bel, Elisabeth H, Maspero, Jorge, Harrison, Timothy, Jackson, David J, Price, David, Lugogo, Njira, Kreindler, James, Burden, Annie, de Giorgio-Miller, Alex, Faison, Sarai, Padilla, Kelly, Martin, Ubaldo J, Garcia Gil, Esther, PONENTE Study Group
BACKGROUND: Oral corticosteroid (OCS) dependence among patients with severe eosinophilic asthma can cause adverse outcomes, including adrenal insufficiency. PONENTE's OCS reduction phase showed that, following benralizumab initiation, 91.5% of patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______109::31d9edc51bacf9669d41910f8f30c2b1
https://www.repository.cam.ac.uk/handle/1810/353625
https://www.repository.cam.ac.uk/handle/1810/353625
Autor:
Menzies-Gow, Andrew, Corren, Jonathan, Bel, Elisabeth H, Maspero, Jorge, Heaney, Liam G, Gurnell, Mark, Wessman, Peter, Martin, Ubaldo J, Siddiqui, Shahid, Garcia Gil, Esther
Benralizumab is an interleukin-5 receptor α-directed cytolytic monoclonal antibody approved in several countries for the add-on maintenance treatment of patients with severe eosinophilic asthma aged 12 years and older. In the 28-week Phase III ZONDA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1fe29c7fc00f1bdae3d594d35668e1b5